Johnson & Johnson (FRA:JNJ)
€ 138.92 -0.18 (-0.13%) Market Cap: 334.68 Bil Enterprise Value: 341.56 Bil PE Ratio: 9.88 PB Ratio: 5.15 GF Score: 83/100

Johnson & Johnson at Cowen Healthcare Conference (Virtual) Transcript

Mar 03, 2021 / 03:20PM GMT
Release Date Price: €129.96 (-1.47%)
Joshua Thomas Jennings
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

Good morning. I'm Josh Jennings from the Cowen Medical Devices team, representing [Brian] Kennedy, Neil Chatterji and Eric Anderson as well. We're starting off the medical devices track on day 3 of the 41st Annual Cowen Healthcare Conference with a one of the leading medical device businesses, but also 2 other important businesses from Johnson & Johnson. And we're thrilled to have Ashley McEvoy, Executive Vice President, Worldwide Chairman for the Medical Devices business.

Ashley, thanks so much for joining today and just a high-level congratulations, and thank you to the Johnson & Johnson team for all the work they've been doing on the vaccine and then the recent emergency use authorization.

Ashley A. McEvoy;Joshua Thomas Jennings
Johnson & Johnson - Executive VP & Worldwide Chairman of Medical Devices;Cowen and Company, LLC, Research Division -

Thank you very kindly, Josh. It's a pleasure to be here.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot